NRX Pharmaceuticals reports first-half 2026 net loss narrows
NRX Pharmaceuticals reported a first-half 2026 net loss of $18.0 million, improved from $23.1 million a year earlier, and said cash rose to $26.7 million at June 30, 2026.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.